At the stage of cerebral ischemia for more than 3 days or recovery, pericytes promote vascular regeneration and accelerate the recovery of blood supply in the ischemic area, in which PDGFR-β and VEGFR can be used as potential therapeutic targets. The gene discussed is PDGFRB; the disease is brain ischemia.